logo

For the Inventor, By the Inventor

Rensselaer, NY, United States of America

Nanopharmaceuticals LLC


USPTO Granted Patents = 21



Forward Citations = 169

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Shaker Ahmed Mousa (21 out of 81 patents)

silverMedal Paul J Davis (13 out of 18 patents)

bronzeMedal Faith B Davis (6 out of 11 patents)

4.  Mehdi Rajabi (5 out of 5 patents)

5.  Ozlem O Karakus (4 out of 4 patents)

6.  Bruce Allan Hay (3 out of 24 patents)

7.  Maria Alexander-Bridges (1 out of 1 patent)

8.  Gennadi V Glinksy (1 out of 1 patent)

9.  Aleck Hercbergs (1 out of 1 patent)

10.  Hung-Yun Lin (1 out of 2 patents)

11.  Gennadi V Glinsky (1 patent)

12.  Shaker A Mousa (0 patent)


21 patents:

1. 11723888 - Polymer conjugated thyrointegrin antagonists (2023-08-15),
2. 11351137 - Composition and method for dual targeting in treatment of neuroendocrine tumors (2022-06-07),
3. 11186551 - Composition of scalable thyrointegrin antagonists with improved retention in tumors (2021-11-30),
4. 11077082 - Composition and method for dual targeting in treatment of neuroendocrine tumors (2021-08-03),
5. 10961204 - Composition of scalable thyrointegrin antagonists with improved blood brain barrier penetration and retention into brain tumors (2021-03-30),
6. 10695436 - Non-cleavable polymer conjugated with alpha V beta 3 integrin thyroid antagonists (2020-06-30),
7. 10328043 - Composition and method for dual targeting in treatment of neuroendocrine tumors (2019-06-25),
8. 10201616 - Non-cleavable polymer conjugated with αVβ3 integrin thyroid antagonists (2019-02-12),
9. 10130686 - Method and composition of thyroid hormone analogues and nanoformulations thereof for treating inflammatory disorders (2018-11-20),
10. 10060934 - Methods for screening patients for resistance to angioinhibition, treatment and prophylaxis thereof (2018-08-28),
11. 9980933 - Thyroid hormone analogs and methods of use (2018-05-29),
12. 9839614 - Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof (2017-12-12),
13. 9750709 - Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof (2017-09-05),
14. 9579300 - Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof (2017-02-28),
15. 9498536 - Method and composition of thyroid hormone analogues and nanoformulations thereof for treating anti-inflammatory disorders (2016-11-22),
NANOPHARMACEUTICALS LLC is a leading biotechnology company specializing in the development and commercialization of innovative nanoparticle-based therapeutics. With a mission to improve patient outcomes, we leverage cutting-edge nanotechnology to engineer targeted drug delivery systems that enhance the efficacy and safety of pharmaceutical treatments. Our team of experienced scientists and researchers collaborate closely with academic institutions and industry partners to revolutionize drug development across various therapeutic areas, including oncology, infectious diseases, and neurology. Visit our website to learn more about our pioneering nanomedicine solutions and ongoing research projects.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

21 Patents

#1 in Rensselaer, NY

#849 in New York

#15,187 in US

#29,088 in the World

...
Rensselaer, NY, United States of America

Nanopharmaceuticals LLC

Forward Citations = 169

10 inventors:

goldMedal Shaker Ahmed Mousa (21 out of 81 patents)

silverMedal Paul J Davis (13 out of 18 patents)

bronzeMedal Faith B Davis (6 out of 11 patents)

4.  Mehdi Rajabi (5 out of 5 patents)

5.  Ozlem O Karakus (4 out of 4 patents)

Please report any incorrect information to support@idiyas.com
Loading…